Pharma Mar S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
141,824.00
149,652.00
193,817.00
180,948.00
179,363.00
162,587
Cost of Goods Sold (COGS) incl. D&A
41,725.00
45,320.00
51,006.00
50,344.00
51,907.00
42,173
Gross Income
100,099.00
104,332.00
142,811.00
130,604.00
127,456.00
120,414
SG&A Expense
95,988.00
103,258.00
123,693.00
140,205.00
137,935.00
126,953
EBIT
3,884.00
8,171.00
9,279.00
8,521.00
10,479.00
16,015
Unusual Expense
86.00
53.00
1,748.00
14.00
-
77
Non Operating Income/Expense
23,289.00
28,478.00
3,722.00
10,592.00
7,359.00
1,873
Interest Expense
6,442.00
6,399.00
5,509.00
5,856.00
5,124.00
4,708
Pretax Income
13,801.00
14,475.00
6,002.00
24,699.00
22,860.00
18,704
Income Tax
1,960.00
1,304.00
654.00
592.00
3,904.00
2,499
Consolidated Net Income
11,841.00
13,171.00
6,656.00
24,107.00
26,764.00
16,205
Net Income
11,841.00
13,171.00
6,656.00
24,082.00
26,745.00
16,187
Net Income After Extraordinaries
12,360.00
13,227.00
6,724.00
24,082.00
26,745.00
26,839
Net Income Available to Common
11,322.00
13,115.00
6,588.00
24,082.00
26,745.00
16,187
EPS (Basic)
0.05
0.06
0.03
0.11
0.12
0.03
Basic Shares Outstanding
220,345.00
219,857.00
220,581.00
220,594.00
220,677.00
220,516
EPS (Diluted)
0.05
0.06
0.03
0.11
0.12
0.03
Diluted Shares Outstanding
221,039.00
220,636.00
221,239.00
221,010.00
220,677.00
220,516
EBITDA
707.00
2,908.00
15,561.00
1,316.00
3,419.00
9,153
Other Operating Expense
7,995.00
9,245.00
9,839.00
1,080.00
-
9,476
Non-Operating Interest Income
752.00
514.00
258.00
256.00
102.00
69
Minority Interest Expense
-
-
-
25.00
19.00
18
About Pharma Mar
View Profile
